Source: Research Seminar 2007 - Severe Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Corrigan (London, United Kingdom). Severe Asthma, Current Options and Limitations of Pharmacotherapy. Research Seminar 2007 - Severe Asthma

Member's Comments

No comment yet.

Related content which might interest you: Problems of Importance in Severe Asthma: A Patient Perspective Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Guideline Adherence and Identifying Cost Effective Medication Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma Source: Guideline 2014 Year: 2014 Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update Source: Eur Respir J 2003; 22: 1 Year: 2003 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007 Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018 Book review - Asthma: Comorbidities, Coexisting Conditions, and Differential Diagnosis Source: Eur Respir Rev 2014; 23: 538 Year: 2014 Diagnosis of Endoscopic Patterns in Severe Asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement? Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists Source: International Congress 2018 – Medical education via the web and the internet Year: 2018 Epidemiology and Triggers of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 2016 China Guideline of Asthma Diagnosis and Management Source: International Congress 2016 – China Session I Year: 2016 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Postinfectious Bronchiolitis Obliterans in Children - Diagnostic Workup and Therapeutic Options - A Workshop Report Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Introduction to The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study Source: Eur Respir J 2002; 20: Suppl. 38, 426s Year: 2002